agree. I’m big on looking at comparable trials to see how recruitment went as that’s often a good guide to the scale of the challenge . Take MPACT panc cancer trial I referred to before (gemcitabine + abraxane) . The published study says it took about 3 years with 150 sites to get 860 patients. That’s about 2 patients per site per year. Unless you think there’s a reason why ACCENT can substantially outperform MPACT , then I’d be using that estimate as a guide.
If that plays out here, with 11 sites, then could take at least a year to get this 26….
- Forums
- ASX - By Stock
- ATX
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-44
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATX (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.4¢ |
Change
0.003(4.92%) |
Mkt cap ! $17.38M |
Open | High | Low | Value | Volume |
6.1¢ | 6.6¢ | 6.1¢ | $28.65K | 462.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 50642 | 5.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.6¢ | 131151 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 50642 | 0.058 |
1 | 42105 | 0.057 |
3 | 233928 | 0.056 |
2 | 256818 | 0.055 |
2 | 97040 | 0.054 |
Price($) | Vol. | No. |
---|---|---|
0.066 | 131151 | 1 |
0.067 | 121201 | 2 |
0.068 | 157750 | 1 |
0.070 | 6009 | 1 |
0.074 | 73026 | 1 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online